Project Grant H8E38918

Numentus Technologies Inc. received a $303,685 Project Grant award from the National Science Foundation on February 15, 2021 to develop rapid planar PCR technology for COVID-19 testing. The award was made under the NSF's Engineering program (CFDA 47.041) to support innovation and excellence in engineering research. Through this funding, Numentus will work to advance the development of planar PCR, a technology that enables highly sensitive COVID-19 detection on a single integrated testing...

This $968,765 Project Grant awarded by the National Science Foundation's (NSF) Division of Mathematical Sciences (CFDA 47.049 - Mathematical and Physical Sciences) will develop a flexible modeling framework to simulate the impact of various testing-based infection control strategies for respiratory pathogens like SARS-CoV-2. The project aims to improve our ability to control existing respiratory diseases and enhance preparedness for future pandemics. Key deliverables include: Developing a...

The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...

Federal Cooperative Agreement Summary The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) awarded the Association of Public Health Laboratories, Inc. (APHL) a $6.98 million Cooperative Agreement under the Emerging Infections Programs (EIP, CFDA 93.317) to enhance public health laboratory capabilities and capacities from July 1, 2025, through June 30, 2030. This five-year award supports APHL's mission to strengthen laboratory infrastructure, surveillance systems, and...

This $200,000 project grant from the National Science Foundation's Computer and Information Science and Engineering program will fund research at the University of California, Berkeley to develop group testing methods for infectious disease monitoring and mitigation. Specifically, the grant supports the creation of specialized machine learning, combinatorial, and information-theoretic techniques to (1) identify low-mutation genomic regions for polymerase chain reaction (PCR) primers, (2) model...

Federal Grant Award Summary Pace Diagnostics, Inc. received a $600,000 Project Grant from the Centers for Disease Control and Prevention (CDC) Office of the Director under the CDC Investigations and Technical Assistance program (CFDA 93.283) for the development and delivery of an ultrasensitive urine tuberculosis (TB) antigen rapid detection test. The award, effective September 30, 2025, with a completion date of March 31, 2026, supports the creation of an innovative diagnostic technology...

This National Science Foundation Technology, Innovation, and Partnerships Project Grant totaling $265,999 will support Rutgers, The State University of New Jersey, Camden in developing a rapid and reliable point-of-care screening for infectious diseases such as COVID-19. Specifically, the university will demonstrate a mass screening method to rapidly detect viruses to identify early infected individuals for quarantine. This work will enable rapid and reliable point-of-care detection with...

Federal Project Grant Award Summary Nanohmics Inc. received a $1,047,807 project grant awarded on September 30, 2025, by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283). The award supports the development of lateral flow-electrochemiluminescent (LF-ECL) test strips and a portable reader device designed to provide ultrasensitive detection of foodborne pathogens. The project extends through September 29, 2027, and is...

Federal Project Grant Award Summary Esper Biosciences Inc. received a $423,833 Project Grant award on September 30, 2025, from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award supports the development of a rapid point-of-care nucleic acid test for Hepatitis C using nanosensor technology. The project will be performed in Ithaca, New York, with a completion date of September 29, 2026, representing a one-year...

Cellbae Inc. received a $174,992 Small Business Innovation Research Project Grant from the US Department of Agriculture National Institute of Food and Agriculture to develop rapid test kits for the detection of Escherichia coli O157:H7 and Salmonella enterica. The goal of the six-month project beginning July 1, 2023 is to verify the sensitivity and specificity of Cellbae's rapid test kit platform, which uses enzymatic amplification to increase detection sensitivity over conventional methods....